SONEPCIZUMAB
UNII O4T5UXS4P2

Substance Identification & Data

This profile provides standardized clinical and technical data for Sonepcizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O4T5UXS4P2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1031360-18-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
O4T5UXS4P2
CAS Registry Number
1031360-18-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SONEPCIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sonepcizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ISONEP
LT1009 (HUMANIZED MONOCLONAL ANTIBODY DIRECTED AGAINST SPHINGOSINE 1-PHOSPHATE)
SONEPCIZUMAB
SONEPCIZUMAB [WHO-DD]

Brand / Trade Names

ASONEP
SPHINGOMAB

Technical Codes

LT1009
LT-1009